FIFTH AMENDMENT TO THE PURCHASE AND SALE AGREEMENT
Exhibit 10.16.5
EXECUTION VERSION
FIFTH AMENDMENT TO THE
PURCHASE AND SALE AGREEMENT
THIS FIFTH AMENDMENT TO THE PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of January 28, 2021, is entered into among each of the entities listed on the signature pages hereto as an Originator (each an “Originator”, and collectively, the “Originators”), and SYNEOS HEALTH, LLC (f/k/a INC RESEARCH, LLC) (“Syneos Health”), as servicer (in such capacity, the “Servicer”) and SYNEOS HEALTH RECEIVABLES LLC (the “Buyer”).
Capitalized terms used but not otherwise defined herein (including such terms used above) have the respective meanings assigned thereto in the Purchase and Sale Agreement described below.
BACKGROUND
A.The parties hereto have entered into a Purchase and Sale Agreement, dated as of June 29, 2018 (as amended, restated, supplemented or otherwise modified through the date hereof, the “Purchase and Sale Agreement”).
B.Concurrently herewith, the Buyer, as borrower, the Servicer and PNC Bank, National Association, as administrative agent and as a lender (the “Administrative Agent”) are entering into that certain Tenth Amendment to Receivables Financing Agreement, dated as of the date hereof (the “RFA Amendment”).
C.Effective as of the January 11, 2021, (such date, the “inVentiv Name Change Date”), inVentiv Commercial Services, LLC, a New Jersey limited liability company, changed its name from “inVentiv Commercial Services, LLC” to “Syneos Health Commercial Services, LLC”.
D.The parties hereto desire to amend the Purchase and Sale Agreement as hereinafter set forth.
NOW THEREFORE, with the intention of being legally bound hereby, and in consideration of the mutual undertakings expressed herein, each party to this Amendment hereby agrees as follows:
SECTION 1.Amendments to the Purchase and Sale Agreement. As of the inVentiv Name Change date, the Purchase and Sale Agreement is hereby amended as follows:
(a)Schedule I to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule I attached hereto.
(b)Schedule II to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule II attached hereto.
(c)Schedule III to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule III attached hereto.
739347366 18569090
(d)Schedule IV to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule IV attached hereto.
SECTION 2.Representations and Warranties of the Originators. Each Originator hereby represents and warrants as of the date hereof as follows:
(a)Representations and Warranties. The representations and warranties made by it in the Purchase and Sale Agreement and each of the other Transaction Documents to which it is a party are true and correct as of the date hereof.
(b)Enforceability. The execution and delivery by it of this Amendment, and the performance of its obligations under this Amendment, the Purchase and Sale Agreement (as amended hereby) and the other Transaction Documents to which it is a party are within its organizational powers and have been duly authorized by all necessary action on its part, and this Amendment, the Purchase and Sale Agreement (as amended hereby) and the other Transaction Documents to which it is a party are (assuming due authorization and execution by the other parties thereto) its valid and legally binding obligations, enforceable in accordance with their terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.
(c)No Event of Default. No Purchase and Sale Termination Event, Unmatured Purchase and Sale Termination Event, Event of Default or Unmatured Event of Default has occurred and is continuing, or would occur as a result of this Amendment or the transactions contemplated hereby.
SECTION 3.Effect of Amendment; Ratification. All provisions of the Purchase and Sale Agreement and the other Transaction Documents, as expressly amended and modified by this Amendment, shall remain in full force and effect. After this Amendment becomes effective, all references in the Purchase and Sale Agreement (or in any other Transaction Document) to “the Purchase and Sale Agreement”, “this Agreement”, “hereof”, “herein” or words of similar effect referring to the Purchase and Sale Agreement shall be deemed to be references to the Purchase and Sale Agreement as amended by this Amendment. This Amendment shall not be deemed, either expressly or impliedly, to waive, amend or supplement any provision of the Purchase and Sale Agreement other than as set forth herein. The Purchase and Sale Agreement, as amended by this Amendment, is hereby ratified and confirmed in all respects.
SECTION 4.Effectiveness. This Amendment shall become effective concurrently with the effectiveness of the RFA Amendment.
SECTION 5.Authorization to File Financing Statement Amendments. Upon the effectiveness of this Amendment, each of the parties hereto hereby authorize the Administrative Agent to file (at the expense of the Buyer) UCC-3 amendments in substantially the form of Exhibit A hereto amending the UCC-1 financing statements identified on Exhibit B hereto.
|
739347366 18569090 |
2 |
|
SECTION 6.Severability. Any provisions of this Amendment which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
SECTION 7.Transaction Document. This Amendment shall be a Transaction Document for purposes of the Receivables Financing Agreement.
SECTION 8.Counterparts. This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart. The words “execution,” “execute”, “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.
SECTION 9.GOVERNING LAW AND JURISDICTION.
(a)THIS AMENDMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF).
(b)EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO (I) WITH RESPECT TO THE BUYER, THE ORIGINATORS AND THE SERVICER, THE EXCLUSIVE JURISDICTION, AND (II) WITH RESPECT TO EACH OF THE OTHER PARTIES HERETO, THE NON-EXCLUSIVE JURISDICTION, IN EACH CASE, OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING (I) IF BROUGHT BY THE BUYER, THE SERVICER, ANY ORIGINATOR OR ANY AFFILIATE THEREOF, SHALL BE HEARD AND DETERMINED, AND (II) IF BROUGHT BY ANY OTHER PARTY TO THIS AMENDMENT, MAY BE HEARD AND DETERMINED, IN EACH CASE, IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. NOTHING IN THIS SECTION 9 SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE
|
739347366 18569090 |
3 |
|
AGENT OR ANY OTHER CREDIT PARTY TO BRING ANY ACTION OR PROCEEDING AGAINST THE BUYER OR THE SERVICER OR ANY OF THEIR RESPECTIVE PROPERTY IN THE COURTS OF OTHER JURISDICTIONS. EACH OF THE BUYER, EACH ORIGINATOR AND THE SERVICER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING. THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.
SECTION 10.Section Headings. The various headings of this Amendment are included for convenience only and shall not affect the meaning or interpretation of this Amendment, the Purchase and Sale Agreement or any provision hereof or thereof.
[Signature pages follow]
|
739347366 18569090 |
4 |
|
IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.
|
|
|
||
|
SYNEOS HEALTH, LLC, |
|||
|
as the Servicer and as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxxx Xxxxx |
||
|
Name: |
Xxxxx Xxxxx |
||
|
Title: |
Chief Financial Officer |
||
|
|
|
||
|
SYNEOS HEALTH COMMERCIAL SERVICES, LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxxx Xxxxx |
||
|
Name: |
Xxxxx Xxxxx |
||
|
Title: |
Manager |
||
|
|
|
||
|
XXXXXXX XXXXXXX LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
|
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
||
|
BIOSECTOR 2 LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
|
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
739347366 18569090 |
S-1 |
Fifth Amendment to the Purchase and Sale Agreement |
IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.
|
SYNEOS HEALTH, LLC, |
||
|
as the Servicer and as an Originator |
||
|
|
|
|
|
By: |
|
|
|
Name: |
Xxxxx Xxxxx |
|
|
Title: |
Manager |
|
|
SYNEOS HEALTH COMMERCIAL SERVICES, LLC, |
||
|
as an Originator |
||
|
|
|
|
|
By: |
|
|
|
Name: |
Xxxxx Xxxxx |
|
|
Title: |
Manager |
|
|
|
|
||
|
XXXXXXX XXXXXXX LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
||
|
BIOSECTOR 2 LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
739347366 18569090 |
S-1 |
Fifth Amendment to the Purchase and Sale Agreement |
|
|
|
||
|
CADENT MEDICAL COMMUNICATIONS, LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
||
|
XXXXXXXXXXX COMMUNICATIONS GROUP LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
||
|
XXXXXXXX CHICCO AGENCY, L.L.C., |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President |
||
|
|
|
||
|
XXXXXX, XXXXX/XXXXXXXXXX ADVERTISING, LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
739347366 18569090 |
S-2 |
Fifth Amendment to the Purchase and Sale Agreement |
|
|
|
||
|
SYNEOS HEALTH MEDICAL COMMUNICATIONS, LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
||
|
NAVICOR GROUP, LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
||
|
PALIO + IGNITE, LLC, |
|||
|
as an Originator |
|||
|
|
|||
|
|
|
||
|
By: |
/s/ Xxxx Xxxxxxx |
||
|
Name: |
Xxxx Xxxxxxx |
||
|
Title: |
Vice President and Assistant Secretary |
||
|
|
|
|
|
THE SELVA GROUP, LLC |
||
|
as an Originator |
||
|
|
||
|
|
|
|
|
By: |
/s/ Xxxx Xxxxxxx |
|
|
Name: |
Xxxx Xxxxxxx |
|
|
Title: |
Vice President and Assistant Secretary |
|
|
739347366 18569090 |
S-3 |
Fifth Amendment to the Purchase and Sale Agreement |
|
|
|
|
|
SYNEOS HEALTH COMMUNICATIONS, INC., |
||
|
as an Originator |
||
|
|
||
|
|
|
|
|
By: |
/s/ Xxxx Xxxxxxx |
|
|
Name: |
Xxxx Xxxxxxx |
|
|
Title: |
Vice President and Secretary |
|
|
|
|
|
|
XXXXXX STRATEGY PARTNERS, LLC, |
||
|
as an Originator |
||
|
|
||
|
|
|
|
|
By: |
/s/ Xxxx Xxxxxxx |
|
|
Name: |
Xxxx Xxxxxxx |
|
|
Title: |
Vice President and Assistant Secretary |
|
|
739347366 18569090 |
S-4 |
Fifth Amendment to the Purchase and Sale Agreement |
|
|
|
|
|
SYNEOS HEALTH RECEIVABLES LLC, |
||
|
as the Buyer |
||
|
|
||
|
|
|
|
|
By: |
/s/ Xxxxxx Xxxxx |
|
|
Name: |
Xxxxxx Xxxxx |
|
|
Title: |
President |
|
|
739347366 18569090 |
S-5 |
Fifth Amendment to the Purchase and Sale Agreement |
Schedule I
LIST AND LOCATION OF EACH ORIGINATOR
|
Originator |
Location |
|
Syneos Health, LLC |
Delaware |
|
Syneos Health Commercial Services, LLC |
New Jersey |
|
Xxxxxxx Xxxxxxx LLC |
North Carolina |
|
BioSector 2 LLC |
|
|
Cadent Medical Communications, LLC |
Ohio |
|
Xxxxxxxxxxx Communications Group LLC |
Delaware |
|
Xxxxxxxx Chicco Agency, L.L.C. |
|
|
Xxxxxx, Xxxxx/Xxxxxxxxxx Advertising, LLC |
Ohio |
|
Syneos Health Medical Communications, LLC |
Ohio |
|
Navicor Group, LLC |
Ohio |
|
Palio + Ignite, LLC |
Ohio |
|
Syneos Health Communications, Inc. |
Ohio |
|
The Selva Group, LLC |
Ohio |
|
Xxxxxx Strategy Partners, LLC |
Ohio |
|
739347366 18569090 |
Schedule I-1 |
Purchase and Sale Agreement (QINC) |
Schedule II
LOCATION OF BOOKS AND RECORDS OF ORIGINATORS
|
Originator |
Location of Books and Records |
|
Syneos Health, LLC |
0000 Xxxx Xxxxxx, Xxxxxxxxxxx, XX 00000 |
|
Syneos Health Commercial Services, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
Xxxxxxx Xxxxxxx LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
BioSector 2 LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
CADENT MEDICAL COMMUNICATIONS, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
Xxxxxxxxxxx Communications Group LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
XXXXXXXX CHICCO AGENCY, L.L.C. |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
XXXXXX, XXXXX/XXXXXXXXXX ADVERTISING, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
Syneos Health Medical Communications, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
NAVICOR GROUP, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
Palio + Ignite, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
Syneos Health Communications, Inc. |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
THE SELVA GROUP, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
Xxxxxx Strategy Partners, LLC |
000 Xxxxxxxx Xxxxxx, 00xx Xxxxx, Xxxxxx, XX 00000 |
|
739347366 18569090 |
Schedule II-1 |
Purchase and Sale Agreement (QINC) |
Schedule III
TRADE NAMES
Syneos Health, LLC
Syneos Health, LLC was formerly known as INC Research, LLC, INC Research, Inc., and Integrated Neuroscience Consortium, Inc.
Syneos Health has been used as a trade name since January 4, 2018.
Syneos Health, LLC has qualified to do business in the State of California.
Syneos Health Commercial Services, LLC
Syneos Health Commercial Services, LLC was formerly known as inVentiv Commercial Services, LLC; Ventiv Commercial Services, LLC; Ventiv Pharma Services, LLC; and Ventiv Health US. Sales LLC.
Syneos Health has been used as a trade name since January 4, 2018.
inVentiv Commercial Services, LLC has qualified to do business in the State of New Jersey and the State of Texas under the name “inVentiv Commercial, LLC”.
Xxxxxxx Xxxxxxx LLC
Xxxxxxx Xxxxxxx LLC was formerly known as AW Acquisition LLC.
BioSector 2 LLC
BioSector 2 LLC was formerly known as Xxxxxx 0 LLC.
Cadent Medical Communications, LLC
Cadent Medical Communications, LLC was formerly known as X.X. Xxxxxxx & Associates, LLC.
Cadent Medical Communications, LLC has qualified to do business in the State of Ohio under the name “Cadent Medical Communications”.
Xxxxxxxxxxx Communications Group LLC
Xxxxxxxxxxx Communications Group LLC was formerly known as Xxxxxxxxxx Communications LLC.
Xxxxxxxx Chicco Agency, L.L.C.
|
739347366 18569090 |
Schedule III -1 |
Purchase and Sale Agreement |
N/A
Xxxxxx, Xxxxx/Xxxxxxxxxx Advertising, LLC
N/A
Syneos Health Medical Communications, LLC
Syneos Health Medical Communications, LLC was formerly known as inVentiv Medical Communications, LLC and inVentiv Medical Education Group, LLC.
Navicor Group, LLC
N/A
Palio + Ignite, LLC
Palio + Ignite, LLC was formerly known as Palio Communications, LLC.
The Selva Group, LLC
N/A
Syneos Health Communications, Inc.
Syneos Health Communications, Inc. was formerly known as inVentiv Health Communications, Inc, inVentiv Communications, Inc., inChord Communications, Inc., Xxxxxx, Xxxxx/Xxxxxxxxxx & Associates, Inc., and Gerbig, Snell, Weisheimer & Associates, Inc.
Syneos Health Communications, Inc. has qualified to do business in the state of New York under the name “inVentiv Communications, Inc.”
Xxxxxx Strategy Partners, LLC
Xxxxxx Strategy Partners, LLC was formerly known as Xxxxxx Search Partners, LLC
|
739347366 18569090 |
Schedule III -2 |
Purchase and Sale Agreement |
Schedule IV
NOTICE ADDRESSES
If to Syneos Health, LLC:
Syneos Health, LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Syneos Health Commercial Services, LLC:
Syneos Health Commercial Services, LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Xxxxxxx Xxxxxxx LLC:
Xxxxxxx Xxxxxxx LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
|
739347366 18569090 |
Schedule IV-1 |
Purchase and Sale Agreement |
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to BioSector 2 LLC:
BioSector 2 LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Cadent Medical Communications, LLC :
Cadent Medical Communications, LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Xxxxxxxxxxx Communications Group LLC :
Xxxxxxxxxxx Communications Group LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
|
739347366 18569090 |
Schedule IV-2 |
Purchase and Sale Agreement |
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Xxxxxxxx Chicco Agency, L.L.C.:
Xxxxxxxx Chicco Agency, L.L.C.
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Xxxxxx, Xxxxx/Xxxxxxxxxx Advertising, LLC:
Xxxxxx, Xxxxx/Xxxxxxxxxx Advertising, LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Syneos Health Medical Communications LLC:
Syneos Health Medical Communications LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
|
739347366 18569090 |
Schedule IV-3 |
Purchase and Sale Agreement |
Attention: Xxxxxx Xxxxx, Esq.
If to Navicor Group, LLC:
Navicor Group, LLC
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Palio + Ignite, LLC:
Palio + Ignite, LLC
c/o Syneos Health, Inc.
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to The Selva Group, LLC:
The Selva Group, LLC
c/o Syneos Health, Inc.
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
|
739347366 18569090 |
Schedule IV-4 |
Purchase and Sale Agreement |
If to Syneos Health Communications, Inc.:
Syneos Health Communications, Inc.
c/o Syneos Health, Inc.
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
If to Xxxxxx Strategy Partners, LLC:
Xxxxxx Strategy Partners, LLC
c/o Syneos Health, Inc.
0000 Xxxx Xxxxxx
Xxxxxxxxxxx, XX 00000
Attention: General Counsel
with a copy to:
Xxxxxx & Xxxxxxx LLP
000 0xx Xxxxxx
Xxx Xxxx, XX 00000-0000
Attention: Xxxxxx Xxxxx, Esq.
|
739347366 18569090 |
Schedule IV-5 |
Purchase and Sale Agreement |
Exhibit A
UCC-3s TO BE FILED
|
739347366 18569090 |
Exhibit A-1 |
Purchase and Sale Agreement |
Exhibit B
UCC-1 TO BE AMENDED
|
Debtor |
Filing Office |
Identification Number |
Filing Date |
|
Syneos Health Commercial Services, LLC (f/k/a inVentiv Commercial Services, LLC) |
New Jersey Secretary of State |
26735252 |
07/25/2019 |
|
739347366 18569090 |
Exhibit B-1 |
Purchase and Sale Agreement |
